 |
|
Quality of life in patients with diabetic nephropathy: findings from the KNOW-CKD (Korean Cohort Study for
Outcomes in Patients with Chronic Kidney Disease) cohort
Hyunsuk Kim, Joongyub Lee, Gwang Ho Choi, Hae Min Jeong, Seok hyung Kim, Jae Eon Gu, Jeong-Ju Yoo, Miyeun Han, Hyo-Jin Kim, Su-Ah Sung, Seung Hyeok Han, Yeong Hoon Kim, Jong-Woo Yoon, Jongho Heo, Kook-Hwan Oh
Kidney Res Clin Pract. 2022;41(1):43-57. Published online 2021 Nov 8 DOI: https://doi.org/10.23876/j.krcp.21.068
|
|
Citations to this article as recorded by
 Unraveling the rationale and conducting a comprehensive assessment of AdipoRon (adiponectin receptor agonist) as a candidate drug for diabetic nephropathy and cardiomyopathy prevention and intervention—a systematic review
Lucas Fornari Laurindo, Lívia Fornari Laurindo, Victória Dogani Rodrigues, Virgínia Maria Cavallari Strozze Catharin, Otávio Augusto Garcia Simili, Gabriella Oliveira Barboza, Vitor Cavallari Strozze Catharin, Kátia Portero Sloan, Sandra Maria Barbalho
Naunyn-Schmiedeberg's Archives of Pharmacology.2024;[Epub] CrossRef The impact of individual case management model on adherence to medical advice and Quality of Life in patients with diabetic nephropathy
Li DONG, Ke PANG, Zhen ZENG, Lian TAN
Panminerva Medica.2024;[Epub] CrossRef
|